FBXO32 and muscle atrophy: Muscle atrophy in cancer cachexia is a complex process characterized by the degradation of skeletal muscle tissue, primarily driven by specific ubiquitin ligases such as muscle atrophy F-box 1 (MAFbx, also known as Atrogin-1) and muscle ring finger protein 1 (MuRF1) (5, 6).